These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2451288)

  • 1. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
    Walker BD; Flexner C; Paradis TJ; Fuller TC; Hirsch MS; Schooley RT; Moss B
    Science; 1988 Apr; 240(4848):64-6. PubMed ID: 2451288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies.
    Seighali N; Shafiee A; Rafiee MA; Aminzade D; Mozhgani SH
    BMC Infect Dis; 2023 May; 23(1):320. PubMed ID: 37170214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
    Sengupta S; Board NL; Wu F; Moskovljevic M; Douglass J; Zhang J; Reinhold BR; Duke-Cohan J; Yu J; Reed MC; Tabdili Y; Azurmendi A; Fray EJ; Zhang H; Hsiue EH; Jenike K; Ho YC; Gabelli SB; Kinzler KW; Vogelstein B; Zhou S; Siliciano JD; Sadegh-Nasseri S; Reinherz EL; Siliciano RF
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2123406119. PubMed ID: 35394875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors.
    Al Ali S; Baldanta S; Fernández-Escobar M; Guerra S
    Viruses; 2016 May; 8(5):. PubMed ID: 27213433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.
    Sanou MP; Roff SR; Mennella A; Sleasman JW; Rathore MH; Yamamoto JK; Levy JA
    J Virol; 2013 Sep; 87(18):10004-15. PubMed ID: 23824804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vaccine Trials: Evolving Concepts and Designs.
    Sanou MP; De Groot AS; Murphey-Corb M; Levy JA; Yamamoto JK
    Open AIDS J; 2012; 6():274-88. PubMed ID: 23289052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239.
    Bosinger SE; Jochems SP; Folkner KA; Hayes TL; Klatt NR; Silvestri G
    J Virol; 2013 Jan; 87(1):433-43. PubMed ID: 23097439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA/KIR restraint of HIV: surviving the fittest.
    Bashirova AA; Thomas R; Carrington M
    Annu Rev Immunol; 2011; 29():295-317. PubMed ID: 21219175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common threads in persistent viral infections.
    Kane M; Golovkina T
    J Virol; 2010 May; 84(9):4116-23. PubMed ID: 19955304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation.
    Mahnke L; Clifford D
    AIDS Res Ther; 2006 Sep; 3():21. PubMed ID: 16970827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.
    Koibuchi T; Allen TM; Lichterfeld M; Mui SK; O'Sullivan KM; Trocha A; Kalams SA; Johnson RP; Walker BD
    J Virol; 2005 Jul; 79(13):8171-81. PubMed ID: 15956562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational approaches to immune regulation.
    Paterson Y
    Immunol Res; 2003; 27(2-3):451-62. PubMed ID: 12857988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.
    Huang Y; Kong WP; Nabel GJ
    J Virol; 2001 May; 75(10):4947-51. PubMed ID: 11312370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans.
    Minev B; Hipp J; Firat H; Schmidt JD; Langlade-Demoyen P; Zanetti M
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4796-801. PubMed ID: 10759561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
    Kalams SA; Goulder PJ; Shea AK; Jones NG; Trocha AK; Ogg GS; Walker BD
    J Virol; 1999 Aug; 73(8):6721-8. PubMed ID: 10400770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD
    J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.
    Harrer T; Schwab J; Struff WG; Schmitt M; Ficker JH; Rödl W; Parsch H; Kalden JR; Gramatzki M
    Infection; 1998; 26(6):368-74. PubMed ID: 9861562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes.
    Smit-McBride Z; Mattapallil JJ; McChesney M; Ferrick D; Dandekar S
    J Virol; 1998 Aug; 72(8):6646-56. PubMed ID: 9658111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
    Brander C; Hartman KE; Trocha AK; Jones NG; Johnson RP; Korber B; Wentworth P; Buchbinder SP; Wolinsky S; Walker BD; Kalams SA
    J Clin Invest; 1998 Jun; 101(11):2559-66. PubMed ID: 9616227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.